What Is a Benzodiazepine Equivalency Chart?
A benzodiazepine equivalency chart compares the relative potency of different benzodiazepines by expressing each medication’s dose as equivalent to a standard reference dose of diazepam (Valium). The chart is an essential tool for physicians managing crossover tapers using the Ashton Manual protocol.
Different benzodiazepines vary significantly in potency, half-life, and onset of action. A patient taking 1mg of alprazolam (Xanax) is receiving a very different pharmacological exposure than a patient taking 1mg of diazepam, even though the milligram amounts are the same.
The equivalency chart resolves this by establishing conversion ratios. Physicians use these ratios to calculate how much diazepam a patient needs when transitioning from their current benzodiazepine during a crossover taper.
Professor C. Heather Ashton published one of the most widely referenced equivalency charts in her Ashton Manual. Her conversions were based on clinical experience with hundreds of patients and remain a foundational reference in benzodiazepine deprescribing.
Understanding equivalency is important for patients as well as physicians. It helps patients recognize the true pharmacological strength of their medication and understand the rationale behind their taper plan.
Benzodiazepine Equivalency Chart: Doses Equivalent to Diazepam 10mg
The following chart shows approximate equivalent doses of commonly prescribed benzodiazepines, using 10mg of diazepam as the reference standard. These values are derived from the Ashton Manual and represent clinical approximations — individual responses may vary.
| Benzodiazepine | Brand Name(s) | Dose Equivalent to Diazepam 10mg | Approximate Half-Life |
|---|---|---|---|
| Diazepam | Valium | 10mg | 20–100 hours |
| Alprazolam | Xanax | 0.5mg | 6–12 hours |
| Clonazepam | Klonopin | 0.5mg | 18–50 hours |
| Lorazepam | Ativan | 1mg | 10–20 hours |
| Temazepam | Restoril | 20mg | 8–22 hours |
| Oxazepam | Serax | 20mg | 4–15 hours |
| Chlordiazepoxide | Librium | 25mg | 5–30 hours |
| Clorazepate | Tranxene | 15mg | 36–200 hours |
These equivalencies are approximations based on clinical data. Individual patients may respond differently to equivalent doses due to differences in metabolism, tolerance, and receptor sensitivity. The chart should be used as a reference alongside clinical judgment, not as a rigid conversion formula.
A physician experienced in benzodiazepine tapering will adjust the crossover doses based on the patient’s actual response rather than relying solely on the chart values. Some patients require slightly more or less diazepam than the standard equivalency suggests.
The half-life column is particularly relevant for understanding withdrawal risk. Shorter half-life medications like alprazolam and oxazepam produce more frequent blood level fluctuations, which increases the likelihood of interdose withdrawal symptoms.
Why Diazepam Is the Reference Standard
Diazepam serves as the reference standard in benzodiazepine equivalency charts for several practical reasons. Its long half-life, low relative potency, and availability in multiple tablet sizes make it the preferred medication for crossover tapers.
The long half-life of diazepam (20 to 100 hours, including active metabolites) produces stable blood levels throughout the day. This stability reduces the peaks and valleys that cause interdose withdrawal symptoms with shorter-acting benzodiazepines.
Diazepam’s lower potency compared to medications like alprazolam or clonazepam means that clinically meaningful doses are expressed in larger milligram amounts. This makes gradual dose reductions easier to achieve using standard tablet formulations.
Diazepam is available as 2mg, 5mg, and 10mg tablets. The 2mg tablet is especially useful for tapering because it allows reductions of 1-2mg at a time, which represents a small percentage of the total dose for most patients.
These pharmacological properties explain why the Ashton Manual and the Maudsley Deprescribing Guidelines both recommend diazepam as the preferred crossover medication for benzodiazepine tapering.
How to Use the Equivalency Chart for a Crossover Taper
The first step in planning a crossover taper is calculating the patient’s total daily benzodiazepine exposure in diazepam equivalents. For a patient taking clonazepam 1mg twice daily (2mg total), the diazepam equivalent is approximately 40mg.
This total equivalent dose determines how much diazepam will ultimately replace the original benzodiazepine. The crossover does not happen all at once — it proceeds in small substitution steps over several weeks, as outlined in the Ashton Manual.
A typical first step might replace half of one daily dose with the equivalent amount of diazepam. For example, replacing a 0.5mg evening clonazepam dose with 10mg of diazepam while keeping the rest of the clonazepam schedule unchanged.
Subsequent substitutions occur at intervals of one to two weeks, with the physician monitoring the patient’s response after each change. The goal is to complete the crossover with minimal disruption before beginning the dose reduction phase.
Once the patient is taking only diazepam, dose reductions proceed gradually. The Ashton Manual recommends cuts of no more than five to ten percent per step, with the pace determined by the patient’s tolerance of each reduction.
Limitations of Benzodiazepine Equivalency Charts
Equivalency charts provide useful clinical estimates, but they are not exact conversion formulas. Individual patients metabolize benzodiazepines at different rates based on genetics, liver function, age, and concurrent medications.
Cross-tolerance between benzodiazepines is not always complete. A patient who has developed tolerance to one specific benzodiazepine may respond somewhat differently to an equivalent dose of another, even when the conversion is pharmacologically accurate.
The equivalency values also do not account for subjective effects. Some patients feel differently on diazepam compared to their original benzodiazepine, even at equivalent doses, due to differences in receptor binding profiles and onset of action.
Elderly patients and those with liver impairment may process diazepam and its active metabolites more slowly. This can result in accumulation effects where the effective dose is higher than the prescribed amount.
For these reasons, the equivalency chart should always be used in conjunction with careful clinical monitoring. A physician experienced in benzodiazepine deprescribing will adjust doses based on patient feedback rather than treating the chart values as absolute.
Equivalency Charts and Compound Pharmacy Formulations
At lower doses during the taper, standard tablet sizes may not allow for sufficiently small reductions. This is where compound pharmacy formulations become essential for implementing the taper plan that the equivalency chart helped design.
Liquid diazepam preparations from compound pharmacies allow reductions as small as fractions of a milligram. A patient tapering from 4mg of diazepam can reduce by 0.25mg at a time, which would be impossible with commercially available tablets alone.
The equivalency chart remains relevant even when using compound formulations because the physician still needs to calculate appropriate dose levels and reduction increments. The chart provides the mathematical framework that the compound pharmacy then implements with precision.
Some patients use compound formulations of their original benzodiazepine when a diazepam crossover is not possible. In these cases, the equivalency chart helps the physician understand the relative potency and plan reduction steps accordingly.
Working with a physician who has established relationships with compound pharmacies ensures that the taper plan can be executed precisely at every stage, from the initial crossover through the final milligram reductions.
Getting Professional Help With a Benzodiazepine Crossover Taper
Using a benzodiazepine equivalency chart to plan a taper requires medical expertise beyond what the chart alone can provide. A physician who specializes in benzodiazepine deprescribing understands how to interpret the equivalencies, adjust for individual patient factors, and manage complications that arise during the process.
The Ashton Manual’s crossover protocols, combined with modern deprescribing research from the Maudsley Guidelines, represent the current best practice for benzodiazepine tapering. Both resources rely on equivalency data as a starting point for individualized treatment planning.
Patients should not attempt to use equivalency charts to self-manage a crossover taper. The pharmacological calculations are only one component of safe tapering — medical monitoring, symptom assessment, and responsive dose adjustments require professional oversight.
Mark Leeds, D.O. uses the Ashton Manual crossover protocol and benzodiazepine equivalency data as foundational tools in developing individualized taper plans. Dr. Leeds combines these with hyperbolic tapering principles and compound pharmacy formulations for precise dosing at every stage.
Patients considering a benzodiazepine taper can schedule a telemedicine consultation with Dr. Leeds to discuss their current medication, equivalent doses, and tapering options. Weekly appointments ensure that the taper proceeds safely with adjustments based on the patient’s actual response.
